Airway management during general anesthesia in elective procedures
Conditions
Interventions
Group 1: Supraglottic airway management with the LT® evo during general anesthesia for elective procedures
Group 2: Supraglottic airway management with the Ambu® AuraGain during general anesthesia for
Sponsors
Johannes Wesling Klinikum Minden, Universitätsklinik für Anästhesiologie, Intensiv- und Notfallmedizin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adult patients (= 18 years) Scheduled elective surgery under general anesthesia requiring a supraglottic airway device ASA classification I–III Fasting status according to current guidelines Written informed consent after adequate explanation
Exclusion criteria
Exclusion criteria: - Known anatomical or functional contraindications to the use of supraglottic airway devices (e.g., known or suspected difficult airway, limited mouth opening, increased risk of aspiration, restricted cervical mobility) - Increased risk of aspiration (e.g., non-fasted patient, clinically relevant gastroesophageal reflux) - Planned fiberoptic intubation or intubation using videolaryngoscopy - ASA classification > III (at the discretion of the attending anesthesiologist) - Severe pulmonary comorbidities with unstable respiratory status - Known hypersensitivity to any of the materials - Participation in another clinical trial that could interfere with airway managemen
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Airway leak pressure (seal pressure of the airway device) at a cuff pressure of 60 cmH2O | — |
Secondary
| Measure | Time frame |
|---|---|
| Success rate of insertion Duration of insertion Ventilation effectiveness Intraoperative stability Postoperative patient-reported complaints | — |
Countries
Germany
Contacts
Public ContactGerrit Jansen
Johannes Wesling Klinikum Minden, Universitätsklinik für Anästhesiologie, Intensiv- und Notfallmedizin
Outcome results
None listed